1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Diagnostic criteria of MR imaging and CT in evaluating tumor invasion into the mandible
Mandibular cortical invasion MRI, CT: Defect of the cortical bone adjacent to the tumor mass Bone marrow involvement MRI: Abnormal signal intensity of bone marrow* contiguous to the cortical defect CT: Trabecular disruption contiguous to the cortical defect Inferior alveolar canal involvement MRI, CT: Bone marrow involvement reaching the inferior alveolar canal
* Hypointense on T1-weighted and hyperintense on fat-suppressed T2-weighted image, with enhancement after contrast administration.